lc20ab system (Shimadzu Corporation)
Shimadzu Corporation is a verified supplier 
Shimadzu Corporation manufactures this product 
90
Structured Review
Shimadzu Corporation
lc20ab system
Lc20ab System, supplied by Shimadzu Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lc20ab+system/qp+2010+plus/us12054482-117-1-1
Average 90 stars, based on 1 article reviews
Lc20ab System, supplied by Shimadzu Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lc20ab+system/qp+2010+plus/us12054482-117-1-1
Average 90 stars, based on 1 article reviews
lc20ab system - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
High Performance Liquid Chromatography:Article Title: TLR8 agonist Article Snippet: .. The Article Title: Quinazoline compound for EGFR inhibition Article Snippet: .. Article Title: Spirocyclic aryl phosphorus oxide and aryl phosphorus sulfide Article Snippet: .. HPLC analyses were performed on a Article Title: Investigation of Inactive-State κ Opioid Receptor Homodimerization via Single-Molecule Microscopy Using New Antagonistic Fluorescent Probes. Article Snippet: .. Analytical HPLC was performed on a Article Title: Discovery of a Novel G-Quadruplex and Histone Deacetylase (HDAC) Dual-Targeting Agent for the Treatment of Triple-Negative Breast Cancer. Article Snippet: The development of triple-negative breast cancer (TNBC) is highly associated with G-quadruplex (G4); thus, targeting G4 is a potential strategy for TNBC therapy.. Because concomitant histone deacetylases (HDAC) inhibition could amplify the impact of G4-targeting compounds, we designed and synthesized two novel series of G4/HDAC dual-targeting compounds by connecting the zinc-binding pharmacophore of HDAC inhibitors to the G4-targeting isaindigotone scaffold (1).. Among the new compounds, a6 with the potent HDAC inhibitory and G4 stabilizing activity could induce more DNA G4 formation than SAHA and 1 in TNBC cells. Article Title: Substituted-indole-compounds as estrogen receptor down-regulators Article Snippet: .. High performance liquid chromatography analysis was performed on a other:Article Title: Pyrrolopyrimidine compounds used as TLR7 agonist Article Snippet: High performance liquid chromatographic analysis is performed with Shimadzu LC20AB system equipped with Shimadzu SIL-20A auto-sampler and Japanese Synthesized:Article Title: Discovery of a Novel G-Quadruplex and Histone Deacetylase (HDAC) Dual-Targeting Agent for the Treatment of Triple-Negative Breast Cancer. Article Snippet: The development of triple-negative breast cancer (TNBC) is highly associated with G-quadruplex (G4); thus, targeting G4 is a potential strategy for TNBC therapy.. Because concomitant histone deacetylases (HDAC) inhibition could amplify the impact of G4-targeting compounds, we designed and synthesized two novel series of G4/HDAC dual-targeting compounds by connecting the zinc-binding pharmacophore of HDAC inhibitors to the G4-targeting isaindigotone scaffold (1).. Among the new compounds, a6 with the potent HDAC inhibitory and G4 stabilizing activity could induce more DNA G4 formation than SAHA and 1 in TNBC cells. |